Literature DB >> 9791531

Monogenetic determinants of Alzheimer's disease: APP mutations.

A M Goate1.   

Abstract

Mutations within exons 16 and 17 of the beta-amyloid precursor protein (APP) gene were the first known cause of familial Alzheimer's disease. These mutations are rare and have been reported in a handful of families exhibiting autosomal dominant inheritance of Alzheimer's disease with age of onset around 50 years. In vitro and in vivo studies have demonstrated that each of these mutations alters proteolytic processing of APP, resulting in an increase in the production of A beta 42, a highly fibrillogenic peptide, that spontaneously aggregates and deposits in the brain. Transgenic mice carrying a mutant human APP gene also show age-dependent beta-amyloid (A beta) deposition in the brain. The rate of deposition in these mice can be modified by apolipoprotein E expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9791531     DOI: 10.1007/s000180050218

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  11 in total

Review 1.  Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.

Authors:  Dennis J Selkoe
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 2.  Cellular mechanisms of beta-amyloid production and secretion.

Authors:  S Sinha; I Lieberburg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's disease.

Authors:  H Kölsch; D Lütjohann; F Jessen; H Urbach; K von Bergmann; W Maier; R Heun
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

4.  Early endosomal abnormalities and cholinergic neuron degeneration in amyloid-β protein precursor transgenic mice.

Authors:  Jennifer H K Choi; Gurjinder Kaur; Matthew J Mazzella; Jose Morales-Corraliza; Efrat Levy; Paul M Mathews
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Rapid and direct transport of cell surface APP to the lysosome defines a novel selective pathway.

Authors:  Angela Lorenzen; Jonathan Samosh; Kenneth Vandewark; Pieter H Anborgh; Claudia Seah; Ana C Magalhaes; Sean P Cregan; Stephen S G Ferguson; Stephen H Pasternak
Journal:  Mol Brain       Date:  2010-04-21       Impact factor: 4.041

6.  Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.

Authors:  L Kulic; J McAfoose; T Welt; C Tackenberg; C Späni; F Wirth; V Finder; U Konietzko; M Giese; A Eckert; K Noriaki; T Shimizu; K Murakami; K Irie; S Rasool; C Glabe; C Hock; R M Nitsch
Journal:  Transl Psychiatry       Date:  2012-11-13       Impact factor: 6.222

7.  Localization and Processing of the Amyloid-β Protein Precursor in Mitochondria-Associated Membranes.

Authors:  Dolores Del Prete; Jan M Suski; Bénédicte Oulès; Delphine Debayle; Anne Sophie Gay; Sandra Lacas-Gervais; Renaud Bussiere; Charlotte Bauer; Paolo Pinton; Patrizia Paterlini-Bréchot; Mariusz R Wieckowski; Frédéric Checler; Mounia Chami
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  The effects of different familial Alzheimer's disease mutations on APP processing in vivo.

Authors:  Steinunn Thordardottir; Anne Kinhult Ståhlbom; Ove Almkvist; Håkan Thonberg; Maria Eriksdotter; Henrik Zetterberg; Kaj Blennow; Caroline Graff
Journal:  Alzheimers Res Ther       Date:  2017-02-16       Impact factor: 6.982

9.  SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans.

Authors:  Chris R Guthrie; Gerard D Schellenberg; Brian C Kraemer
Journal:  Hum Mol Genet       Date:  2009-03-09       Impact factor: 5.121

10.  Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer's disease: transgene and endogenous APP genes are regulated tissue-specifically.

Authors:  Cansu Agca; Jason J Fritz; Lary C Walker; Allan I Levey; Anthony Ws Chan; James J Lah; Yuksel Agca
Journal:  BMC Neurosci       Date:  2008-02-26       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.